Capital Partners III Llc Aisling serves as Executive at Durata Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Capital Partners III Llc Aisling has executed 16 insider transactions totaling $52.3M, demonstrating a bullish approach to their equity position. Their most recent transaction on Dec 19, 2017 involved selling 250,000 shares valued at $20.1M.
Capital Partners III Llc Aisling currently holds 3,438,920 shares of Durata Therapeutics, Inc. (DRTX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Capital Partners III Llc Aisling has been a net buyer of DRTX stock. They have purchased $32.2M and sold $20.1M worth of shares.
Capital Partners III Llc Aisling's most recent insider trade was on Dec 19, 2017, when they sold 250,000 shares at $80.50 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Jul 6, 2016 | SYRS | $5.0M | Purchase | 400,000 | $12.50 | Discretionary |
| Jun 2, 2016 | AGRX | $0 | Other | 400,000 | $N/A | Discretionary |
| May 17, 2016 | LOXO | $5.0M | Purchase | 232,558 | $21.50 | Discretionary |
| Dec 9, 2015 | TTOO | $3.0M | Purchase | 307,692 | $9.75 | Discretionary |
| Nov 17, 2015 | LOXO | $7.0M | Purchase | 265,000 | $26.50 | Discretionary |
| Nov 13, 2015 | LOXO | $53.7K | Purchase | 1,955 | $27.47 | Discretionary |
| Nov 12, 2015 | LOXO | $2.1M | Purchase | 76,714 | $27.65 | Discretionary |
| Jan 23, 2014 | ZLTQ | $0 | Other | 4,715 | $N/A | Discretionary |
| Jan 23, 2014 | ZLTQ | $0 | Other | 994,305 | $N/A | Discretionary |
| Jan 23, 2014 | ZLTQ | $0 | Other | 4,697 | $N/A | Discretionary |
| Jan 23, 2014 | ZLTQ | $0 | Other | 2,398 | $N/A | Discretionary |
| Jan 23, 2014 | ZLTQ | $0 | Other | 1,152 | $N/A | Discretionary |
| Jul 24, 2012 | DRTX | $10.0M | Purchase | 1,111,111 | $9.00 | Discretionary |
| Jul 24, 2012 | DRTX | $0 | Conversion | 2,019,713 | $N/A | Discretionary |